Effects of the "Big Squeeze" can be seen in manufacturer budget cuts, restricted and/or misallocated sales resources, incorrect financial accruals, investment uncertainty, and increased risk of inaccurate forecasting. Another impact is the growing cost burden that patients face as a result of expanding access controls and cost management.

• Rising trends of patient cost exposure and demand for support
• Current impact and future risks of deductible accumulators and copay maximizers
• Holistic patient management beyond the co-pay card
• Implications of potential policy changes

Speaker

Jeff Thiesen
Senior Principal, US Market Access Consulting & Analytics
IQVIA